DK524884A - Farmaceutiske praeparater indeholdende phosphatidylserin og fremgangsmaade til fremstilling deraf - Google Patents

Farmaceutiske praeparater indeholdende phosphatidylserin og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK524884A
DK524884A DK524884A DK524884A DK524884A DK 524884 A DK524884 A DK 524884A DK 524884 A DK524884 A DK 524884A DK 524884 A DK524884 A DK 524884A DK 524884 A DK524884 A DK 524884A
Authority
DK
Denmark
Prior art keywords
phosphaty
dylserine
procedures
preparing
pharmaceutical preparations
Prior art date
Application number
DK524884A
Other languages
English (en)
Other versions
DK524884D0 (da
DK168271B1 (da
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of DK524884D0 publication Critical patent/DK524884D0/da
Publication of DK524884A publication Critical patent/DK524884A/da
Application granted granted Critical
Publication of DK168271B1 publication Critical patent/DK168271B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Resins (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Heat Treatment Of Steel (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK524884A 1983-11-17 1984-11-02 Farmaceutiske præparater indeholdende phosphatidylserin og fremgangsmåde til fremstilling deraf DK168271B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4935583 1983-11-17
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Publications (3)

Publication Number Publication Date
DK524884D0 DK524884D0 (da) 1984-11-02
DK524884A true DK524884A (da) 1985-05-18
DK168271B1 DK168271B1 (da) 1994-03-07

Family

ID=11270453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524884A DK168271B1 (da) 1983-11-17 1984-11-02 Farmaceutiske præparater indeholdende phosphatidylserin og fremgangsmåde til fremstilling deraf

Country Status (25)

Country Link
US (1) US4595680A (da)
EP (1) EP0148045B1 (da)
JP (1) JPH0676334B2 (da)
KR (1) KR870001330B1 (da)
AT (1) ATE35415T1 (da)
AU (1) AU572228B2 (da)
BE (1) BE901074A (da)
CH (1) CH661734A5 (da)
DE (1) DE3472406D1 (da)
DK (1) DK168271B1 (da)
ES (1) ES8608528A1 (da)
FI (1) FI79946C (da)
FR (1) FR2555050B1 (da)
GR (1) GR80951B (da)
HU (1) HU193302B (da)
IE (1) IE58130B1 (da)
IL (1) IL73420A (da)
IN (1) IN162717B (da)
IT (1) IT1212900B (da)
LU (1) LU85639A1 (da)
MX (1) MX160792A (da)
NO (1) NO164275C (da)
NZ (1) NZ210091A (da)
PT (1) PT79510B (da)
ZA (1) ZA848776B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471776A1 (fr) * 1979-12-21 1981-06-26 Oreal Nouveaux agents cosmetiques a base de polymeres cationiques, compositions cosmetiques les contenant, et leur application
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
IT1247165B (it) * 1991-03-15 1994-12-12 Fidia Spa Uso terapeutico della fosfatidilserina e derivati in patologie degenerative anche associate a disfunsioni immunitarie.
IT1248012B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
GB9621293D0 (en) * 1996-10-11 1996-11-27 Scotia Holdings Plc Formulations containing unsaturated fatty acids
US20030147944A1 (en) * 1999-12-10 2003-08-07 Mayer Lawrence D Lipid carrier compositions with protected surface reactive functions
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
TWI281407B (en) * 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
CA2319928A1 (en) 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
WO2003013549A2 (de) * 2001-08-09 2003-02-20 Degussa Food Ingredients Gmbh Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
WO2003088949A2 (de) * 2002-04-19 2003-10-30 Bioghurt Biogarde Gmbh & Co. Kg. Matrix mit einer bioaktiven phospholipid-haltigen komponente
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
CN1308334C (zh) * 2004-06-01 2007-04-04 山东师范大学 一种从动物脑提取磷脂酰丝氨酸的方法
IL182372A0 (en) * 2007-04-01 2008-01-20 Enzymotec Ltd Compositions containing phosphatidylserine in treating diabetes-associated conditions
ITMI20121784A1 (it) * 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
WO2015069870A1 (en) * 2013-11-07 2015-05-14 The University Of North Carolina At Chapel Hill Particles containing phospholipids or bioactive fatty acid
IT202100032252A1 (it) * 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3156616A (en) * 1958-11-14 1964-11-10 Canada Majesty In Right Of Composition and method for correcting foods and blood conditions having clot promoting characteristics
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine
FR5060M (da) * 1965-12-22 1967-05-08
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder

Also Published As

Publication number Publication date
EP0148045A1 (en) 1985-07-10
NO164275C (no) 1990-09-19
AU3563084A (en) 1985-05-30
DK524884D0 (da) 1984-11-02
KR870001330B1 (ko) 1987-07-18
HU193302B (en) 1987-09-28
ES8608528A1 (es) 1986-07-16
ZA848776B (en) 1986-06-25
HUT35957A (en) 1985-08-28
IN162717B (da) 1988-07-02
KR850003504A (ko) 1985-06-20
IT1212900B (it) 1989-11-30
JPH0676334B2 (ja) 1994-09-28
JPS60132921A (ja) 1985-07-16
FI79946C (fi) 1990-04-10
BE901074A (nl) 1985-05-17
LU85639A1 (fr) 1985-06-04
AU572228B2 (en) 1988-05-05
US4595680A (en) 1986-06-17
CH661734A5 (fr) 1987-08-14
FI844468A0 (fi) 1984-11-14
IT8349355A0 (it) 1983-11-17
FR2555050B1 (fr) 1986-12-26
ES537575A0 (es) 1986-07-16
PT79510A (en) 1984-12-01
IE58130B1 (en) 1993-07-14
FR2555050A1 (fr) 1985-05-24
FI844468L (fi) 1985-05-18
EP0148045B1 (en) 1988-06-29
MX160792A (es) 1990-05-17
ATE35415T1 (de) 1988-07-15
NO844585L (no) 1985-05-20
IE842785L (en) 1985-05-17
IL73420A (en) 1988-06-30
DK168271B1 (da) 1994-03-07
PT79510B (en) 1986-09-08
FI79946B (fi) 1989-12-29
DE3472406D1 (en) 1988-08-04
NO164275B (no) 1990-06-11
NZ210091A (en) 1988-06-30
GR80951B (en) 1984-12-18
IL73420A0 (en) 1985-02-28

Similar Documents

Publication Publication Date Title
DK524884A (da) Farmaceutiske praeparater indeholdende phosphatidylserin og fremgangsmaade til fremstilling deraf
ES8700934A1 (es) Procedimiento para la obtencion de liposomas
IL72120A (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ATE26115T1 (de) Substituierte 8-phenylxanthine.
IT1150608B (it) Complessi platino-diamminici e procedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi
EP0652755A1 (en) THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE.
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
AU581855B2 (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
ES8200871A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina
ATE24716T1 (de) Lenkotrien-antagonisten.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed